Vol. 34 No. 1 (2024)

Published: 07-05-2024

View Vol. 34 No. 1 (2024)

Editorials

Confinia Cephalalgica: a new start

Pierangelo Geppetti

https://doi.org/10.4081/cc.2024.15766

373

PDF: 30
- PDF

Original Research Articles

ID-Migraine test for pediatric population: preliminary results from the Italian validation

Ilaria Frattale, Laura Papetti, Fabiana Ursitti, Giorgia Sforza, Gabriele Monte, Luigi Mazzone, Massimiliano Valeriani

https://doi.org/10.4081/cc.2024.15761

318

PDF: 30
- PDF
Prospective evaluation of aura during anti-calcitonin gene-related peptide monoclonal antibody therapy after 52 weeks of treatment

Marina Romozzi, Andrea Burgalassi, Catello Vollono, Maria Albanese, Giulia Vigani, Francesco De Cesaris, Alberto Chiarugi, Paolo Calabresi, Luigi Francesco Iannone

https://doi.org/10.4081/cc.2024.15762

394

PDF: 18
- PDF
Normative values of the nociceptive blink reflex habituation

Michele Corrado, Elena Mazzotta, Gloria Vaghi, Francescantonio Cammarota, Federico Bighiani, Alessandro Antoniazzi, Daniele Martinelli, Maria Magdalena Pocora, Luca Martinis, Valentina Grillo, Sara Bottiroli, Armando Perrotta, Giuseppe Cosentino, Grazia Sances, Cristina Tassorelli, Roberto De Icco

https://doi.org/10.4081/cc.2024.15730

212

PDF: 21

SUPPLEMENTARY MATERIAL: 2
- PDF
- SUPPLEMENTARY MATERIAL
Anti-CGRP monoclonal antibodies improve cognitive function in patients affected by chronic migraine complicated with medication overuse-headache

Simona Guerzoni, Flavia Lo Castro, Carlo Baraldi, Daria Brovia, Fabio Tascedda, Veronica Rivi, Luca Pani

https://doi.org/10.4081/cc.2024.15760

228

PDF: 15
- PDF

© PAGEPress 2008-2024 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy